Therapy Of Post-Covid Fibrotic Changes

dc.contributor.authorAbdumanapova Rano Kakhramanovna
dc.date.accessioned2026-01-02T11:32:59Z
dc.date.issued2023-05-13
dc.description.abstractAmong the extensive manifestations of post-covid syndrome, cough is often found. Most researchers interpret its nature as post-infectious. In some patients, postinfectious cough becomes productive and effective treatment requires combined mucoactive therapy. Also, since the beginning of the pandemic, enough clinical observations of spontaneous pneumothorax have accumulated in the literature. The risk of this complication is present even in patients who are not burdened with chronic lung diseases, as well as in spontaneous breathing. The study of the mechanisms of development of spontaneous pneumothorax in COVID-19 is necessary for the development of further therapeutic and preventive measures. Traction bronchiectasis occurs in 27–52.5% of cases of novel coronavirus infection (NCI).
dc.formatapplication/pdf
dc.identifier.urihttps://geniusjournals.org/index.php/emrp/article/view/4164
dc.identifier.urihttps://asianeducationindex.com/handle/123456789/77589
dc.language.isoeng
dc.publisherGenius Journals
dc.relationhttps://geniusjournals.org/index.php/emrp/article/view/4164/3534
dc.sourceEurasian Medical Research Periodical; Vol. 20 (2023): EMRP; 89-91
dc.source2795-7624
dc.subjectCOVID-19
dc.subjectcough
dc.subjectpost-COVID syndrome
dc.titleTherapy Of Post-Covid Fibrotic Changes
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typePeer-reviewed Article

item.page.files

item.page.filesection.original.bundle

pagination.showing.labelpagination.showing.detail
loading.default
thumbnail.default.alt
item.page.filesection.name
kakhramanovna_2023_therapy_of_post-covid_fibrotic_changes.pdf
item.page.filesection.size
268.47 KB
item.page.filesection.format
Adobe Portable Document Format

item.page.collections